HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Calcium modulation in epilepsy.

Abstract
The ideal antiepileptic drug (AED) should correct the aberrant pathophysiology of epileptogenesis without interfering with normal neurotransmission A new group of drugs with antiepileptic efficacy, without sedative properties, would be an exciting prospect. Theoretical considerations and results from experimental animal models of epilepsy have put forward the possibility that calcium (Ca2+) antagonists may form such a group. The initiation of epileptogenic activity in the neuron is thought to be connected with the phenomenon known as "intrinsic burst firing", which is activated by an inward Ca2+ current. Ca2+ is described as the primary mediator of "excitotoxic" neuronal damage. Both necrotic and apoptotic cell death is associated with Ca2+ entry into the cells during status epilepticus. The Ca2+ channel blockers depressed epileptic depolarizations of neurons. In this review, we present anticonvulsant effects of cinnarizine, flunarizine, nifedipine, nimodipine, nicardipine, amlodipine, isradipine, niguldipine, diltiazem, verapamil and dantrolene in animal models of seizures. Also, a detailed analysis of interactions between Ca2+ blockers and AEDs was performed. Clinical trials in intractable epilepsy support to a certain degree antiepileptic properties of Ca2+ antagonists.
AuthorsWojciech Kułak, Wojciech Sobaniec, Katarzyna Wojtal, Stanisław J Czuczwar
JournalPolish journal of pharmacology (Pol J Pharmacol) 2004 Jan-Feb Vol. 56 Issue 1 Pg. 29-41 ISSN: 1230-6002 [Print] Poland
PMID15047975 (Publication Type: Journal Article, Review)
Chemical References
  • Anticonvulsants
  • Calcium Channel Blockers
  • Calcium
Topics
  • Animals
  • Anticonvulsants (pharmacology, therapeutic use)
  • Calcium (antagonists & inhibitors, metabolism)
  • Calcium Channel Blockers (pharmacology, therapeutic use)
  • Cross-Over Studies
  • Double-Blind Method
  • Epilepsy (drug therapy, epidemiology, physiopathology)
  • Humans
  • Poland

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: